Market Cap $71.91M
!
Corporate Spotlight
Compumedics is at an inflection point—scaling FDA-cleared platforms (Somfit®), commercializing world-class neuroimaging (OrionMEG®), and building recurring SaaS revenues. Combined with strong FY25 execution and a Board focused on capital markets, CMP is poised to unlock both operational growth and a
View the full Corporate Spotlight
CMP charges forward following record breaking year
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| CMP | MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY | 17:02 | 1 | 191 | |||
|
|||||||
| CMP | Compumedics locks in $5M sales order for its MEG brain imaging tech | 11/12/25 | 3 | 951 | |||
|
|||||||
| CMP | Ann: 5th & New MEG Order | 10/11/25 | 0 | 603 | |||
|
|||||||
| CMP | Ann: Application for quotation of securities - CMP | 05/11/25 | 0 | 164 | |||
|
|||||||
| CMP | Ann: Canaccord Drug and Device Conference 2025 | 02/11/25 | 5 | 1.4K | |||
|
|||||||
| CMP | Ann: Initial Director's Interest Notice | 30/10/25 | 0 | 146 | |||
|
|||||||
| CMP | Ann: Results of Meeting | 30/10/25 | 0 | 126 | |||
|
|||||||
| CMP | Ann: Chair's Address to Shareholders | 30/10/25 | 0 | 188 | |||
|
|||||||
See All Discussions
Timeline
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
| View More | |||||
ASX News